Ensure early development plans incorporate a biomarker strategy and leverage PK/ PD modeling to establish an exposure-response relationship that optimizes dose selection, facilitates the efficiency of the overall program development plans and enables Clinical, Director, Business Operations, Clinic, Lead, Product Development, Healthcare